Since IL-1β does not directly inhibit tumour cell proliferation (Supporting Information Fig S9B and S9D), the underlying mechanisms involved in the IL-1β-mediated inhibitory effect in vivo most likely occur through an indirect paracrine manner. This evidence concerns the gene IL1B and neoplasm.